Efficacy and Safety of Lumiracoxib in Patients With Primary Knee Osteoarthritis (OA)
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This 39-week, active controlled, study is designed to assess long-term efficacy, safety and
tolerability of lumiracoxib 100mg od in patients with osteoarthritis (OA) of the knee who
participated in the 13-week core CCOX189A2361 study.